No Data
No Data
SINOLIFE UTD [03332] is currently reported at 0.63 Hong Kong dollars, with a decline of 10.00%.
As of 14:11, SINOLIFE UTD [03332] is reported at HK$0.63, down HK$0.07 or 10.00% from yesterday's closing price of HK$0.70, with a transaction value of HK$0.0013 million. Today's highest price is HK$0.63, and the lowest price is HK$0.63. Based on yesterday's closing price, the 10-day average price is HK$0.67, the 50-day average price is HK$0.62, and the current PE is 11.42 times, with a 14-day strength index of 86.36.
What does AI pharmaceuticals still lack before a market explosion? | Focus
① From the discovery of targets to the identification of preclinical candidate compounds, current generative AI mainly focuses on the early stages of drug development, which can lead to significant acceleration; ② If AI in drug development is to further expand the realm of possibilities, it must explore more profitable real-world applications.
SINOLIFE UTD (03332) converts 0.674 billion domestic shares into Listed in Hong Kong.
SINOLIFE UTD (03332) announced that on December 30, 2024, it will convert 0.674 billion domestic shares into 6...
SINOLIFE UTD (03332.HK) was increased by Executive Director and Chairman Gui Pinghu by 0.35 million shares.
On December 16, according to the latest equity disclosure information from the Stock Exchange, from December 10 to December 12, 2024, SINOLIFE UTD (03332.HK) was acquired by Executive Director and Chairman Gui Pinghu, who purchased a total of 350,000 shares at an average price of HKD 0.6345-0.6541 per share, involving approximately HKD 225,000. After the acquisition, Gui Pinghu's latest holding number is 24.332 million shares, and the shareholding ratio increased from 8.80% to 8.93%.
Sinolife Utd (03332): Chen Xiu and Lu Jiachun re-elected as employee representative supervisors of the company.
sinolife utd (03332) issued an announcement, and after approval by the shareholders, the board of directors decided to appoint Mr. Ye Bangyin as a member of the board of directors...
SINOLIFE UTD: INTERIM REPORT 2024